Male Breast Cancer After a 20 Years of Treated Testicular Cancer, A Case Report

Mohammad Al-Share, Mohammad Abu Jeyyab

Abstract


Breast cancer in male gender is rare with an incidence of 1 % of all breast cancers. There are many theories and risk factors that play a role in the development of breast cancer among males. The development of a second primary cancer is also rare. Herein we have a case of a male breast cancer that devolved after a 20 years of treated testicular cancer. There are many risk factors that should be studied to know correlation between the two diseases. In this case report we will show the presentation of the patient, discuss the risk factors and put our treatment plan.

Keywords


Breast cancer, Testicular cancer, Mass, lump, Case report

Full Text:

PDF

References


(1) Rusner C, Streller B, Stegmaier C, Trocchi P, Kuss O, McGlynn KA, Trabert B, Stang A.Risk of second primary cancers after testicular cancer in East and West Germany: a focus oncontralateral testicular cancers. Asian J Androl. 2014 Mar-Apr;16(2):285-9. doi: 10.4103/1008- 682X.122069. PMID: 24407180; PMCID: PMC3955342.

(2) Karayiannakis AJ, Kakolyris S, Kouklakis G, Chelis L, Bolanaki H, Tsalikidis C, Simopoulos C. Synchronous breast and rectal cancers in a man. Case Rep Oncol. 2011May;4(2):281-6. doi: 10.1159/000328995. Epub 2011 May 25. PMID: 21734883; PMCID: PMC3124462.

(3) Grenader T, Goldberg A, Shavit L. Second cancers in patients with male breast cancer: a literature review. J Cancer Surviv. 2008 Jun;2(2):73-8. doi: 10.1007/s11764-008-0042-5. Epub 2008 Apr 1. PMID: 18648975.

(4) Weiss, Joli R., Kirsten B. Moysich, and Helen Swede. "Epidemiology of male breast cancer." Cancer Epidemiology and Prevention Biomarkers 14.1 (2005): 20-26.‏

(5) Liu N, Johnson KJ, Ma CX. Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis. Clin Breast Cancer. 2018 Oct;18(5):e997-e1002. doi: 10.1016/j.clbc.2018.06.013. Epub 2018 Jun 27. PMID: 30007834.

(6) Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A. Epidemiology of male breast cancer. Breast. 2020 Dec;54:8-14. doi: 10.1016/j.breast.2020.08.010. Epub 2020 Aug 22. PMID: 32866903; PMCID: PMC7476060.

(7) Niewoehner CB, Schorer AE. Gynaecomastia and breast cancer in men. BMJ. 2008;336(7646):709-713. doi:10.1136/bmj.39511.493391.BE

(8) Liang, F., Zhang, S., Xue, H., & Chen, Q. (2017). Risk of second primary cancers in cancer patients treated with cisplatin: A systematic review and meta-analysis of randomized studies. BMC Cancer, 17(1). https://doi.org/10.1186/s12885-017-3902-4

(9) Gómez-Raposo, C., Tévar, F. Z., Moyano, M. S., Gómez, M. L., & Casado, E. (2010). Male breast cancer. Cancer treatment reviews, 36(6), 451-457.‏

(10) Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010 Jan 10;28(2):232-9. doi: 10.1200/JCO.2009.23.8162. Epub 2009 Dec 7. PMID: 19996029; PMCID: PMC2815713.

(11) Giordano, Sharon H. "A review of the diagnosis and management of male

(12) breast cancer." The oncologist 10.7 (2005): 471-479

Rudlowski C. Male Breast Cancer. Breast Care (Basel). 2008;3(3):183-189. doi:10.1159/000136825




DOI: https://doi.org/10.7575/aiac.abcmed.v.10n.2p.1

Refbacks

  • There are currently no refbacks.


Bookmark and Share


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

2013-2023 (CC-BY) Australian International Academic Centre PTY.LTD.

Advances in Bioscience and Clinical Medicine